These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36684674)

  • 1. Low temperature upregulating HSP70 expression to mitigate the paclitaxel-induced damages in NHEK cell.
    Chen L; Xu Y
    PeerJ; 2023; 11():e14630. PubMed ID: 36684674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low temperature mitigating the paclitaxel-induced damages in mouse cell and hair follicle model.
    Chen L; Xu Y; Ye X
    Biochem Biophys Res Commun; 2022 May; 603():94-101. PubMed ID: 35279463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparable effectiveness of 45- and 20-min post-infusion scalp cooling time in preventing paclitaxel-induced alopecia - a randomized controlled trial.
    Lugtenberg RT; van den Hurk CJG; Smorenburg CH; Mosch L; Houtsma D; Deursen MAGDH; Kaptein AA; Gelderblom H; Kroep JR
    Support Care Cancer; 2022 Aug; 30(8):6641-6648. PubMed ID: 35501515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Scalp Cooling on the Pharmacokinetics of Paclitaxel.
    van Doorn L; van Rosmalen MM; van der Deure WM; Oomen-de Hoop E; Porrazzo R; Wijngaard SM; Boere IA; Veenstra P; Ibrahim E; de Bruijn P; Friberg LE; Koolen SLW; Mathijssen RHJ; Jager A
    Cancers (Basel); 2021 Aug; 13(15):. PubMed ID: 34359815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study.
    Giarratano T; Frezzini S; Zanocco M; Giorgi CA; Mioranza E; Miglietta F; Griguolo G; Falci C; Faggioni G; Tasca G; Di Liso E; Vernaci G; Menichetti A; Mantiero M; Grosso D; Guarneri V; Dieci MV
    Breast J; 2020 Jul; 26(7):1296-1301. PubMed ID: 31837103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia.
    Komen MM; Smorenburg CH; van den Hurk CJ; Nortier JW
    Oncologist; 2013; 18(7):885-91. PubMed ID: 23650021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention.
    Dunnill CJ; Al-Tameemi W; Collett A; Haslam IS; Georgopoulos NT
    Oncologist; 2018 Jan; 23(1):84-96. PubMed ID: 28951499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of scalp cooling during anthracycline containing chemotherapy depend on scalp skin temperature.
    Komen MMC; Smorenburg CH; Nortier JWR; van der Ploeg T; van den Hurk CJG; van der Hoeven JJM
    Breast; 2016 Dec; 30():105-110. PubMed ID: 27689316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer.
    Carbognin L; Accetta C; Di Giorgio D; Fuso P; Muratore M; Tiberi G; Pavese F; D'Angelo T; Fabi A; Giannarelli D; Di Leone A; Magno S; Garganese G; Sanchez AM; Terribile DA; Franceschini G; Masetti R; Scambia G; Paris I
    Curr Oncol; 2022 Sep; 29(10):7218-7228. PubMed ID: 36290846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.
    Cigler T; Isseroff D; Fiederlein B; Schneider S; Chuang E; Vahdat L; Moore A
    Clin Breast Cancer; 2015 Oct; 15(5):332-4. PubMed ID: 25749072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness, Safety, and Tolerance of Scalp Cooling for Chemotherapy-Induced Alopecia.
    Zhang XY; Yang KL; Liu WQ; Huang J; Ning N
    Oncol Nurs Forum; 2022 Jun; 49(4):369-384. PubMed ID: 35788740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulation of scalp cooling by external devices for prevention of chemotherapy-induced alopecia.
    Pliskow B; Mitra K; Kaya M
    J Therm Biol; 2016 Feb; 56():31-8. PubMed ID: 26857974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final results of a prospective study of scalp cooling in preventing chemotherapy-induced alopecia.
    Orlando L; Loparco D; Fedele P; Schiavone P; Quaranta A; Caliolo C; Cinefra M; Rizzo P; Calvani N; Morleo A; Varriano R; Bonuso V; Falcone LL; Caloro M; Cinieri S
    Future Oncol; 2019 Oct; 15(29):3337-3344. PubMed ID: 31578891
    [No Abstract]   [Full Text] [Related]  

  • 14. Scalp cooling: management option for chemotherapy-induced alopecia.
    Roe H
    Br J Nurs; 2014 Sep 11-24; 23(16):S4, S6, S8 passim. PubMed ID: 25203854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review.
    Marks DH; Okhovat JP; Hagigeorges D; Manatis-Lornell AJ; Isakoff SJ; Lacouture ME; Senna MM
    Breast Cancer Res Treat; 2019 Jun; 175(2):267-276. PubMed ID: 30806923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients.
    Ridderheim M; Bjurberg M; Gustavsson A
    Support Care Cancer; 2003 Jun; 11(6):371-7. PubMed ID: 12768403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer.
    van den Hurk CJ; van den Akker-van Marle ME; Breed WP; van de Poll-Franse LV; Nortier JW; Coebergh JW
    Eur J Oncol Nurs; 2013 Oct; 17(5):536-40. PubMed ID: 23571182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Influence of Various Parameters on the Success of Sensor-Controlled Scalp Cooling in Preventing Chemotherapy-Induced Alopecia.
    Schaffrin-Nabe D; Schmitz I; Josten-Nabe A; von Hehn U; Voigtmann R
    Oncol Res Treat; 2015; 38(10):489-95. PubMed ID: 26451590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
    Rugo HS; Klein P; Melin SA; Hurvitz SA; Melisko ME; Moore A; Park G; Mitchel J; Bågeman E; D'Agostino RB; Ver Hoeve ES; Esserman L; Cigler T
    JAMA; 2017 Feb; 317(6):606-614. PubMed ID: 28196257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy.
    Komen MMC; van den Hurk CJG; Nortier JWR; van der Ploeg T; Nieboer P; van der Hoeven JJM; Smorenburg CH
    Support Care Cancer; 2019 May; 27(5):1919-1925. PubMed ID: 30206728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.